Natera NTRA 深 沪
等待开盘 09-17 09:30:00 美东时间
175.01
+2.850
+1.66%
华盛通- 最 高175.40
- 今 开173.00
- 成交量 80.11万股
- 最 低 171.5774
- 昨 收 172.16
- 总市值 239.76亿
- 52周最高 183.00
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 117.27
- 委 比 86.99%
- 总股本 1.37亿
- 历史最高 183.00
- 量 比 0.81
- 振 幅 2.22%
- 历史最低 6.52
- 每 手 1
- 风险率 15.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多If You Invested $100 In Natera Stock 5 Years Ago, You Would Have This Much Today
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 8.4% ...
09-16 06:30
Cuba hit by nationwide blackout as grid collapses again
Cuba’s fragile power grid suffered its fourth nationwide collapse in less than a year on Wednesday, leaving the island’s 10 million residents without electricity. Officials said the system went down j...
09-11 00:36
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initi...
08-30 05:00
NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims
NeoGenomics wins a North Carolina court ruling invalidating key Natera patents, clearing the way for its RaDaR ST assay and boosting investor sentiment.
08-30 01:04
NeoGenomics rallies after court win in Natera patent dispute
NeoGenomics (NASDAQ:NEO) shares climbed ~20% in the premarket on Friday after the company announced a major victory in a legal battle over a patent dispute with its rival cancer test developer Natera ...
08-29 20:45
NeoGenomics Secures Court Ruling Invalidating Natera's Patents; Case Dismissed With Prejudice
– NeoGenomics wins summary judgment in patent infringement lawsuit against Natera; Court rules Natera's patents are invalid for claiming ineligible subject matter– NeoGenomics remains free to make, use, sell, and promote
08-29 19:11
Natera Announces Activation Of NRG Oncology Trial, ARCHER, Randomized, Phase III Study In Muscle-Invasive Bladder Cancer
Randomized study aims to reduce treatment burden for patients and utilizes Signatera to monitor for disease recurrenceNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced
08-28 20:10
American Regent® Launches Gvoke VialDx™ (glucagon injection)
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
08-27 20:35
Cathie Wood Just Dropped $12.9 Million On This Trendy Robotaxi Stock, Ark Also Loads Up On Amazon Shares
Tuesday, Cathie Wood-led Ark Invest made notable trades involving Amazon, Pony AI, and Archer Aviation, reflecting strategic positioning in key tech sectors.
08-13 09:48
